Antal Rot

Professor Antal Rot holds a Chair in Inflammation Sciences at Queen Mary University of London (QMUL), within the William Harvey Research Institute (Faculty of Medicine and Dentistry) and the Centre for Inflammation and Therapeutic Innovation. He is also a Wellcome Trust Investigator. Previously, he served as Head of Experimental Pathology at Sandoz/Novartis Forschungsinstitut in Vienna for 20 years and held professorial roles at the Universities of Birmingham and York. His research focuses on chemokine receptors' roles in inflammation and immune response mechanisms.

• Education: M.D. from Semmelweis University (Budapest, Hungary), followed by post-doctoral training at the National Cancer Institute (USA).
• Career Path: Transitioned from industry (Sandoz/Novartis) to academia in the UK since 2017.

Research Interests: Molecular mechanisms of inflammation, chemokine receptor function (e.g., ACKR1, ACKR4), immune cell trafficking, and their roles in diseases like glomerulonephritis and cancer. His work bridges basic science and translational research, with emphasis on chemokine dynamics and receptor biology.

Publications: Over 100 key papers, including high-impact studies in Nat Immunol and Ann Rev Immunol, focusing on chemokine receptor roles in immunity and disease. Recent work explores ACKR4 in kidney pathology and CXCR4 in erythropoiesis.

• Grants/Sponsors: Wellcome Trust, Versus Arthritis, Swiss National Science Foundation.
• Collaborators: Institutions in Germany, Switzerland, Austria (e.g., LMU Munich, ETH Zurich).
• Labs: Leads the Rot Lab at the Centre for Microvascular Research, specializing in inflammatory processes and chemokine biology.